Natural killer cells and missing-self recognition

In one sentence

Natural killer cells integrate activating and inhibitory signals, and reduced normal self-display can remove part of the inhibition that restrains them.

The intuition

A security check can ask both “Is something suspicious present?” and “Is a reassuring credential missing?” Natural killer cells use both kinds of information. Missing a credential raises concern, but the final response still depends on other signals. There is no automatic kill command attached to an empty badge holder.

How it works

Natural killer (NK) cells are lymphocytes with innate recognition systems. Unlike conventional T cells, they do not rely on a rearranged antigen-specific T-cell receptor (TCR). Their surface receptors instead integrate signals from several partners.

Some inhibitory receptors recognize particular human leukocyte antigen (HLA) class I molecules. When those expected self signals are reduced, inhibition can weaken. This is called missing-self recognition. The original experiments used mouse lymphoma cells missing mouse display molecules; they established a principle, not a guarantee for all human tumors. Kärre and colleagues’ primary study makes that context explicit.

Activating inputs also matter. They can include stress-associated molecules on a target cell and signals from antibody-coated targets. The NK cell’s previous education, local environment and capacity to act affect the result. Human experiments show that receptor context and cytokine stimulation can change responsiveness. Juelke et al. studied this under defined laboratory conditions.

NK cells can release molecules that damage target cells and can produce signaling proteins. They can also become inhibited in a tumor environment. Losing HLA may help a cancer evade some T cells while exposing a possible NK vulnerability. The word “possible” matters: these are interacting systems, not a guaranteed biological trade.

Why it matters in cancer

NK recognition helps explain why different immune cells can notice different vulnerabilities. It also motivates engineered NK therapies. A missing-self mechanism does not establish that such a therapy reaches a solid tumor, persists or benefits a patient.

Worked example

A fictional tumor loses one HLA allele. A TCR restricted to that allele may lose its display route. It does not follow that every NK cell now attacks: other inhibitory signals may remain, and activating signals may be inadequate. A functional assay must test the actual cell–target pair.

Common confusions

NK cells and natural killer T cells are different cell families.
Loss of one HLA allele is not loss of all class I expression.
“Innate” does not mean unregulated or always active.
Missing self is a recognition principle, not a treatment-selection test.

Sources and scope

Source check: October 9, 2026. General NK recognition, with animal and human experiments distinguished. Expert and learner review remain pending.